Standard Biotools (LAB) Assets Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Assets Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 127.77 Bn | 124.29 Bn | 4.50 Bn |
| 3 | Medtronic | 119.02 Bn | 109.80 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.90 Mn | -223.82 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.61% |
| Mar 31, 2026 | 10.27% |
| Dec 31, 2025 | -7.28% |
| Sep 30, 2025 | -20.82% |
| Jun 30, 2025 | -21.41% |
| Mar 31, 2025 | -25.47% |
| Dec 31, 2024 | 89.54% |
| Sep 30, 2024 | 100.88% |
| Jun 30, 2024 | 99.18% |
| Mar 31, 2024 | 109.24% |
| Dec 31, 2023 | -17.23% |
| Sep 30, 2023 | -18.23% |
| Jun 30, 2023 | -19.34% |
| Mar 31, 2023 | 36.67% |
| Dec 31, 2022 | 41.82% |
| Sep 30, 2022 | 47.03% |
| Jun 30, 2022 | 52.47% |
| Mar 31, 2022 | -10.90% |
| Dec 31, 2021 | -15.26% |
| Sep 30, 2021 | -12.63% |